动脉瘤性蛛网膜下腔出血监测性血管造影的效用:223例连续患者的回顾性研究
该质量改进项目回顾性分析单中心5年内223例动脉瘤性蛛网膜下腔出血患者,其中157例接受按方案第7天血管造影,66例接受按需血管内补救治疗。两组人口学特征相似,仅后者平均年龄更高(p=0.016)。按方案造影组血管造影次数显著更多(p<0.001),住院费用显著更高(240,327美元 vs 205,719美元,p=0.03),而脑梗死发生率、ICU住院时间、住院时间、出院去向及出院改良Rankin评分均无显著差异。作者认为这一队列比较对aSAH患者常规按方案脑血管造影的做法提出了质疑。
要点
- 按方案第7天血管造影组住院费用显著高于按需治疗组(240,327美元 vs 205,719美元,p=0.03)。
- 按方案造影组血管造影次数显著多于非方案组(p<0.001)。
- 两组脑梗死发生率、ICU住院时间、住院时间、出院去向及出院改良Rankin评分均无显著差异。
- 非方案组平均年龄高于方案组(p=0.016),其余人口学特征相似。
- 作者认为该结果对aSAH患者常规按方案脑血管造影的做法提出质疑。
适用人群与场景
- 单中心5年内连续纳入的动脉瘤性蛛网膜下腔出血患者,排除未接受动脉瘤治疗者及年龄<18岁者。
处置流程与药物剂量
- 按方案第7天血管造影组接受第7天血管造影监测血管痉挛;非方案组接受按需血管内补救治疗。
研究设计与关键结果
- 回顾性队列比较223例aSAH患者,按方案第7天血管造影组157例,非方案组66例。
- 非方案组平均年龄高于方案组(p=0.016),其余人口学特征相似。
- 按方案造影组血管造影次数显著更多(p<0.001)。
- 按方案造影组住院费用显著更高(240,327美元 vs 205,719美元,p=0.03)。
- 两组脑梗死发生率、ICU住院时间、住院时间、出院去向及出院改良Rankin评分均无显著差异。
证据类型、等级与局限
- 证据类型:单中心回顾性队列比较(质量改进项目)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该队列比较分析对aSAH患者常规按方案脑血管造影的做法提出质疑。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with aneurysmal subarachnoid hemorrhage (aSAH) who survive the rupture are at risk for delayed neurologic deficits and cerebral infarction. The ideal method(s) of surveillance for cerebral vasospasm, and the link between radiographic vasospasm and delayed neurologic deficits, remain controversial. We instituted a postbleed day 7 angiography protocol with the stated goals of identification of vasospasm, improving neurologic outcomes, and possibly lowering cost of care.
METHODS: We conducted a quality improvement project in which we retrospectively analyzed consecutive cases of aSAH from a single institution over a 5-year period. Patients were excluded if they did not receive treatment for their aneurysm or were < 18 years of age. We analyzed demographic and outcome information for patients managed by protocolled angiography versus those who were managed by as-needed endovascular rescue therapy. Statistical tests were performed comparing means and proportions in both cohorts, as appropriate.
RESULTS: In total, 223 patients were identified who met inclusion criteria. In total, 157 patients were identified in the protocolled day 7 angiography group, and 66 were in the nonprotocolled angiography group. Demographics were similar between the day 7 angiogram and medical management cohorts, except for a higher mean age among the latter group (p = 0.016). The protocolled angiography group underwent a significantly greater number of angiograms (p < 0.001) and had a significantly higher cost of hospitalization ($240,327 vs. $205,719, p = 0.03), with no significant difference in rate of cerebral infarction, length of intensive care unit stay, length of hospital stay, discharge location, or discharge modified Rankin Score.
CONCLUSIONS: This cohort comparison analysis draws into question the practice of protocolized cerebral angiography in patients with aSAH.
参考来源
- Kole MJ, Martinez-Gutierrez JC, Zeineddine HA, et al. Utility of Surveillance Angiography in Aneurysmal Subarachnoid Hemorrhage: A Retrospective Study of 223 Consecutive Patients. Neurocrit Care. 2023. PMID: 38093091. doi:10.1007/s12028-023-01892-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。